Berberine and Diabetes — How It Works, What the Studies Show, and Safe Dosing
Dr. Joseph Mercola - Take Control of Your Health
Briana Mercola
4.6 • 1.6K Ratings
🗓️ 4 February 2026
⏱️ 8 minutes
🧾️ Download transcript
Summary
- A 2022 meta-analysis of 37 randomized trials found that berberine lowered glycated hemoglobin by 0.63% and fasting glucose by 0.82 mmol/L, with consistent results across diverse patient groups
- Earlier researchers also highlighted how berberine lowers blood sugar and harmful blood fats while also reducing liver fat and markers linked to kidney damage
- Berberine limits fat cell development and dampens inflammation as well, effects that may support weight control and improved insulin sensitivity
- In a 13‑week randomized study, researchers showed that berberine's blood sugar-lowering abilities are on par with the effects of the diabetes drug metformin
- Clinical studies support taking 500 mg of berberine with meals up to three times daily, starting with lower doses and increasing gradually; however, there are safety precautions to keep in mind
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Could a time-tested plant compound lower your A1C, improve fasting glucose within weeks, |
| 0:06.0 | and even rival metformin in head-to-head research, while maintaining a favorable safety profile for most users? |
| 0:13.0 | Welcome to Dr. Mercola's cellular wisdom. Stay informed with quick, easy-to-listen summaries of our latest articles, |
| 0:19.0 | perfect for when you're on the go. No reading required. |
| 0:22.3 | Subscribe for free at Mercola.com for the latest health insights. |
| 0:26.3 | Hello and welcome to Dr. Mercola's cellular wisdom. I'm Ethan Foster. Today we're examining |
| 0:32.3 | berberine and type 2 diabetes, how it works, what clinical studies show, and how dosing has been used safely |
| 0:39.3 | in trials. |
| 0:40.3 | I'm a Lara Sky. |
| 0:42.3 | You'll hear the numbers from randomized controlled trials, how berberine activates AMPK |
| 0:47.3 | to support energy regulation, what newer formulations have achieved, and the practical intake |
| 0:52.8 | guidelines that studies have used. |
| 0:55.3 | Your starting point is the AMPK pathway. AMPK acts as an energy sensor, and when it's activated, |
| 1:02.5 | you increase cellular glucose uptake, shift fuel use toward fat burning, curb liver glucose |
| 1:08.8 | production, and reduce inflammation and oxidative stress. |
| 1:13.0 | Berberene is one of the alkaloids known to trigger this pathway, which helps explain |
| 1:17.2 | its recurrent benefits in metabolic studies. A large 22 meta-analysis pooled 37 randomized trials |
| 1:24.5 | with 3,048 participants who had type 2 diabetes. |
| 1:29.5 | Across those studies, Berberine reduced fasting plasma glucose by an average of 0.82 |
| 1:34.9 | millimoles per liter, lowered HBA 1C by 0.63 percentage points, and cut two-hour post-meal |
| 1:42.7 | glucose by 1.16 millimoles per liter. |
| 1:46.0 | People starting with higher fasting glucose, an A1C, saw greater drops, |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Briana Mercola, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Briana Mercola and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.